Familial pheochromocytoma

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 4, 2008, Pages 361-363

  Bissada, Mary A ^a   Safwat, Ahmed S ^a   Seyam, Raouf M ^b   Al Sobhi, Saif ^b   Hanash, Kamal A ^b   Bissada, Nabil K ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Adrenal; Hypertension; Multiple endocrine neoplasia; Neuroectodermal syndromes; Pheochromocytoma

Indexed keywords

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HEREDITARY PHEOCHROMOCYTOMA; HUMAN; LAPAROSCOPIC SURGERY; MALE; MORTALITY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY; THYROID CARCINOMA; TREATMENT OUTCOME; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES;

EID: 45849090362     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.03.025     Document Type: Article

References (10)

1. Tank E.S., Gelbard M.K., and Blank B. Familial pheochromocytomas. J Urol 128 (1982) 1013-1016
2. O'Connor D.T. The adrenal medulla, catecholamines, and pheochromocytoma. In: Goldman L., and Ausiello D. (Eds). Cecil Textbook of Medicine. 22nd ed. (2004), W.B. Saunders, Philadelphia 1419-1424
3. Sutton M.G., Sheps S.G., and Lie J.T. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56 (1981) 354-360
4. Steiner A.L., Goodman A.D., and Powers S.R. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism, and Cushing's disease; multiple endocrine neoplasia, Type 2. Medicine 47 (1968) 371-409
5. Schinike R.N., Hartmann W.H., Prout T.E., et al. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromaffin tissue. N Engl J Med 279 (1968) 1-7
6. Ponder B.A., Ponder M.A., Coffey R., et al. Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet 1 (1988) 397-401
7. Nguyen L., Niccoli-Sire P., Caron P., et al. Pheochromocytoma in multiple endocrine neoplasia type 2: A prospective study. Eur J Endocrinol 144 (2001) 37-44
8. Yip L., Lee J.E., Shapiro S.E., et al. Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198 (2004) 525-535
9. Patocs A., Karadi E., Toth M., et al. Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: An analysis of 41 cases investigated in a single endocrine centre. Eur J Cancer Prev 13 (2004) 403-409
10. Walz M.K., Alesina P.F., Wenger F.A., et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: Results of 161 tumors in 126 patients. World J Surg 30 (2006) 899-908